• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management.

作者信息

Cerio Rino, Dirschka Thomas, Dréno Brigitte, Figueras Nart Ignasi, Lear John T, Pellacani Giovanni, Peris Ketty, de Casas Andrés Ruiz

机构信息

Department of Cutaneous Medicine and Surgery, The Royal London Hospital and QMUL, Bart's Health NHS Trust, E1 1BB London, United Kingdom.

出版信息

Acta Derm Venereol. 2017 Aug 31;97(8):997-998. doi: 10.2340/00015555-2692.

DOI:10.2340/00015555-2692
PMID:28448101
Abstract
摘要

相似文献

1
Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management.光化性角化病，一种慢性进行性疾病：了解临床差距以优化患者管理。
Acta Derm Venereol. 2017 Aug 31;97(8):997-998. doi: 10.2340/00015555-2692.
2
Online consensus conferences for the development and update of clinical practice guidelines: A survey among participants of the German S3 guideline on actinic keratosis and cutaneous squamous cell carcinoma.用于制定和更新临床实践指南的在线共识会议：对德国关于光化性角化病和皮肤鳞状细胞癌的S3指南参与者的一项调查
J Dtsch Dermatol Ges. 2021 Apr;19(4):608-610. doi: 10.1111/ddg.14397. Epub 2021 Feb 22.
3
Commentary on the "Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis" Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum.关于国际皮肤科协会联盟与欧洲皮肤病学会合作发布的《光化性角化病治疗的循证和共识（S3）指南》的评论。
Skin Pharmacol Physiol. 2018;31(3):144-146. doi: 10.1159/000486687. Epub 2018 Apr 3.
4
Actinic keratoses.光化性角化病
Cancer Treat Res. 2009;146:227-39. doi: 10.1007/978-0-387-78574-5_20.
5
Incidence of Actinic Keratosis and Risk of Skin Cancer in Subjects with Actinic Keratosis: A Population-based Cohort Study.光化性角化病患者的光化性角化病发病率及皮肤癌风险：一项基于人群的队列研究。
Acta Derm Venereol. 2018 Mar 13;98(3):382-383. doi: 10.2340/00015555-2854.
6
The value of the histopathologic examination in the diagnosis and management of the actinic keratosis.组织病理学检查在光化性角化病诊断和治疗中的价值。
Rom J Morphol Embryol. 2012;53(4):927-34.
7
[Not Available].[无可用内容]
Praxis (Bern 1994). 2016 Sep;105(18):1071-7. doi: 10.1024/1661-8157/a002459.
8
Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.光化性角化病治疗的当前方案及指南意义：2011年冬季临床皮肤病学会议临床圆桌会议纪要
Cutis. 2011 Jul;88(1):suppl 1-8.
9
Actinic Keratosis Pathogenesis Update and New Patents.光化性角化病发病机制的最新进展与新专利
Recent Pat Inflamm Allergy Drug Discov. 2016;10(1):40-48. doi: 10.2174/1872213x10666160504104825.
10
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.意大利光化性角化病管理的关键意见领袖（KOL）共识：AKTUAL研讨会
G Ital Dermatol Venereol. 2013 Oct;148(5):515-24.

引用本文的文献

1
Hundred Most Cited Articles in Actinic Keratosis: A Bibliometric Analysis.光化性角化病领域被引用次数最多的100篇文章：一项文献计量分析
Indian J Dermatol. 2024 Sep-Oct;69(5):422. doi: 10.4103/ijd.ijd_273_23. Epub 2024 Oct 29.
2
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials.光化性角化病自发消退率：一项随机对照试验的系统评价和荟萃分析。
Sci Rep. 2022 Apr 7;12(1):5884. doi: 10.1038/s41598-022-09722-8.
3
Method of Assessing Skin Cancerization and Keratoses (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.
皮肤癌化和角化评估方法（MASCK™）：一种用于评估广泛皮肤癌化患者的新型临床评估工具，在多个解剖部位的开发和摄影验证。
Clin Exp Dermatol. 2022 Jun;47(6):1144-1153. doi: 10.1111/ced.15136. Epub 2022 Mar 22.
4
How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results.如何评估光化性角化病干预措施的疗效？一项聚焦长期结果的综述
J Clin Med. 2021 Oct 15;10(20):4736. doi: 10.3390/jcm10204736.
5
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?免疫检查点阻断在晚期皮肤鳞状细胞癌中的应用：2020 年我们对此了解多少？
Int J Mol Sci. 2020 Dec 6;21(23):9300. doi: 10.3390/ijms21239300.
6
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.光化性角化病患者的治疗动机与期望：一项德国范围内的多中心横断面试验。
J Clin Med. 2020 May 12;9(5):1438. doi: 10.3390/jcm9051438.
7
Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.长期干预光化性角化病的疗效：系统评价和网络荟萃分析方案。
Syst Rev. 2019 Oct 11;8(1):237. doi: 10.1186/s13643-019-1156-8.
8
Updates on Treatment Approaches for Cutaneous Field Cancerization.皮肤场癌化治疗方法的最新进展
Curr Dermatol Rep. 2019 Sep;8(3):122-132. doi: 10.1007/s13671-019-00265-2. Epub 2019 Jul 19.